Healthcare Services

Diabetic Retinopathy Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Diabetic Retinopathy Market Over The Period 2026–2030?

The diabetic retinopathy market has demonstrated significant expansion in recent years. It is projected to increase from $9.26 billion in 2025 to $9.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The historical growth trajectory is largely a result of factors including the rising incidence of diabetes, delayed identification of retinal damage, restricted availability of screening, an increase in vision impairment cases, and a reliance on hospital-based eye care.

The diabetic retinopathy market is projected to experience robust expansion over the coming years. Its value is set to reach $13.54 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.0%. This anticipated market expansion during the forecast period stems from the advancement of AI-assisted screening tools, the increased establishment of ophthalmology clinics, greater adoption of anti-VEGF therapy, a heightened emphasis on preventive eye care, and the expanding elderly diabetic demographic. Key developments anticipated in the forecast period involve the increased uptake of retinal screening initiatives, more widespread application of anti-VEGF therapies, the broadening of early detection and monitoring efforts, the expanding integration of AI-powered retinal imaging, and an intensifying focus on preserving vision.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12187&type=smp

Which Economic Or Industry Drivers Are Impacting The Diabetic Retinopathy Market?

The escalating occurrence of diabetes is anticipated to stimulate expansion within the diabetic retinopathy market. Diabetes is characterized as a long-term metabolic condition leading to elevated blood glucose levels. This increase in diabetes prevalence is largely attributable to factors such as overweight, obesity, genetic predispositions, and insufficient physical activity. Patients suffering from diabetes often have excessive sugar in their bloodstream, which has the potential to damage the retina—the eye component that senses light and relays signals to the brain through a nerve located at the back of the eye. For instance, in March 2024, the Office for Health Improvement and Disparities, a UK-based government department, reported that from March 2022 to March 2023, the proportion of individuals with type 1 diabetes receiving all eight recommended care processes advanced by 22%, while for type 2 diabetes, this figure increased by 21%. Additionally, the percentage of people achieving target HbA1c levels reached 37.9%, marking the highest value ever documented by the National Diabetes Audit. Therefore, the growing prevalence of diabetes is a significant impetus for the diabetic retinopathy market’s development.

How Is The Diabetic Retinopathy Market Divided Into Its Major Segments?

The diabetic retinopathy market covered in this report is segmented –

1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy

2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment

2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR

What Key Trends Are Influencing The Development Of The Diabetic Retinopathy Market?

Leading companies within the diabetic retinopathy market are concentrating on partnerships to enhance their market profitability. Collaborations in diabetic retinopathy involve joint initiatives among various stakeholders, such as healthcare providers, researchers, pharmaceutical firms, and advocacy groups, to address challenges linked with the condition. For instance, in October 2023, AEYE Health, a US-based provider of AI-based diagnostics for retinal imaging, partnered with Topcon Screen, a Japan-based diabetic screening platform. The objective of their partnership is to offer artificial intelligence-powered point-of-care screening for diabetic retinopathy, guaranteeing rapid and accurate results, allowing primary care clinicians to conduct diabetic retinopathy screenings directly in their clinics. This methodology aims to decrease non-compliance and close care gaps associated with diabetic retinopathy screening by providing instant, precise assessments at the point of care.

Who Are The Prominent Organizations Shaping The Diabetic Retinopathy Market?

Major companies operating in the diabetic retinopathy market are Pfizer Inc., F‑Hoffmann‑La Roche Ltd., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co Ltd., IRIDEX Corporation, Alimera Science Inc., Oxurion NV, EyePoint Pharmaceuticals, Opthea Limited, KalVista Pharmaceuticals Inc., Regenxbio Inc., Kodiak Sciences Inc., Oculis, Verseon International Corporation, Clearside Biomedical Inc.

Read the full diabetic retinopathy market report here:

https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

What Are The Top-Performing Regions Within The Diabetic Retinopathy Market?

North America was the largest region in the diabetic retinopathy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Diabetic Retinopathy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12187&type=smp

Browse Through More Reports Similar to the Global Diabetic Retinopathy Market 2026, By The Business Research Company

Non Proliferative Diabetic Retinopathy Global Market Report

https://www.thebusinessresearchcompany.com/report/non-proliferative-diabetic-retinopathy-global-market-report

Proliferative Diabetic Retinopathy Pdr Global Market Report

https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report

Diabetic Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795